AIFC · AI Financial Corp
$0.41
-0.01 (-3.21%)
At close · Aug 14
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed May 18, 2026
Market Cap
$57.01M
Shares
139.84M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | President and Secretary | $700,459 |
| Virland A. Johnson | Chief Financial Officer | $87,692 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | President, Chief Executive Officer, and Secretary | $817,709 |
| Virland A. Johnson | Chief Financial Officer | $349,346 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | President, Chief Executive Officer, and Secretary | $625,324 |
| Virland A. Johnson | Chief Financial Officer | $250,324 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | President, Chief Executive Officer, and Secretary | $550,324 |
| Virland A. Johnon | Chief Financial Officer | $149,363 |
| Virland A. Johnson | Chief Financial Officer | $149,363 |
| Eric Bolling | Former President | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | President, Chief Executive Officer, and Secretary | $534,471 |
| Eric Bolling | Former President | $355,645 |
| Virland A. Johnon | Chief Financial Officer | $121,731 |
| Virland A. Johnson | Chief Financial Officer | $121,731 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Eric Bolling | President | $648,077 |
| Tony Isaac | Chief Executive Officer | $571,427 |
| Virland A. Johnson | Chief Financial Officer | $125,274 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Tony Isaac | Chief Executive Officer | $805,119 |
| Virland A. Johnson | Chief Financial Officer | $308,559 |
| Eric Bolling | President | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tony Isaac | Chief Executive Officer | Appointed | 2026-04-24 |
| Tim Stanley | independent director | Appointed | 2026-02-06 |
| Dr. Adel ElMessiry, Ph.D. | independent director | Appointed | 2026-02-04 |
| Steven M. Plumb | Chief Financial Officer | Appointed | 2026-01-28 |
| Peter Tassiopoulos | board of directors | Resigned | 2025-12-12 |
| Peter Tassiopoulos | Chief Executive Officer | Resigned | 2025-12-12 |
| Tony Isaac | Acting Chief Executive Officer | Appointed | 2025-11-26 |
| David Danziger | member of the Board | Resigned | 2025-11-26 |
| Steven Plumb | Chief Financial Officer | Appointed | 2025-11-26 |
| Jonathan Hugh | Acting Chief Executive Officer | Terminated | 2025-11-26 |
| Ron Pitters | Chief Operating Officer | Terminated | 2025-11-26 |
| Jonathan Hugh | Chief Financial Officer | Terminated | 2025-11-26 |
| Jonathan Hugh | Acting Chief Executive Officer | Appointed | 2025-10-22 |
| Zachary Folkman | director | Appointed | 2025-08-29 |
| Zachary Witkoff | Chairman of the Board | Appointed | 2025-08-29 |
| David Danziger | member of our Board of Directors | Appointed | 2025-07-03 |
| Peter Tassiopoulos | Chief Executive Officer | Appointed | 2024-08-30 |
| Dr. John Bonfiglio | Interim President of JanOne Biotech | Appointed | 2023-03-21 |
Key facts
CIK
862861
CUSIP
47089W104
13F (30d)
73 filings
71 filers
Visit website
Investor relations